Stockscreener 앱 받기
1.46
2.82%
0.04
시간 외 거래:
1.46
Edesa Biotech Inc 주식(EDSA)의 최신 뉴스
Does Edesa Biotech Inc stock benefit from AI growthEarnings Overview Report & Safe Entry Trade Reports - baoquankhu1.vn
Shorts Report: Will Edesa Biotech Inc stock gain from government policiesMarket Risk Analysis & Accurate Intraday Trade Tips - Bộ Nội Vụ
Is Edesa Biotech Inc. stock positioned for digital transformationShare Buyback & Stepwise Trade Execution Plans - Улправда
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Edesa Biotech Inc. stock could be next big winnerDaily Trainer Picks & quick comparison of popular models - Улправда
Is Edesa Biotech Inc. stock vulnerable to regulatory risksMarket Performance Recap & Free Reliable Trade Execution Plans - Улправда
Edesa Biotech, Inc.Common Shares (NQ: EDSA - FinancialContent
Published on: 2026-01-06 14:04:13 - ulpravda.ru
Market Recap: How robust is Invesco Bloomberg Analyst Rating Improvers stock financial positionMarket Performance Recap & Long-Term Safe Investment Plans - moha.gov.vn
What is the fair value of Edesa Biotech Inc. stock nowForecast Cut & Community Trade Idea Sharing - Улправда
Is Edesa Biotech Inc. stock supported by strong fundamentals2025 AllTime Highs & Daily Technical Stock Forecast Reports - Улправда
Will Edesa Biotech Inc. stock recover faster than peersBond Market & Stepwise Swing Trade Plans - DonanımHaber
Diluted earnings per share (diluted EPS) of Edesa Biotech, Inc. – BOATS:EDSA - TradingView — Track All Markets
Why analysts remain bullish on Edesa Biotech Inc. stockGap Down & Breakout Confirmation Alerts - Улправда
S P Trends: Is Edesa Biotech Inc. stock supported by strong fundamentals2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Zacks Small Cap Comments on Edesa Biotech Q1 Earnings - Defense World
Zacks Small Cap Forecasts Edesa Biotech FY2028 Earnings - Defense World
EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026 - Zacks Small Cap Research
Edesa Biotech advances dermatology and respiratory programs in fiscal 2025 - MSN
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025 - TipRanks
Edesa Biotech increases at-the-market offering limit to $2.26 million - Investing.com
[8-K] Edesa Biotech, Inc. Reports Material Event | EDSA SEC FilingForm 8-K - Stock Titan
[424B5] Edesa Biotech, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Edesa Biotech, Inc. SEC 10-K Report - TradingView — Track All Markets
Edesa Biotech, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Edesa Biotech (NASDAQ: EDSA) details fiscal 2025 results press release - Stock Titan
Edesa Biotech Reports Fiscal Year 2025 Results - The Manila Times
Edesa Biotech Reports Fiscal Year 2025 Financial Results and Updates on Clinical Programs | EDSA Stock News - Quiver Quantitative
Edesa Biotech, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
How buybacks impact Edesa Biotech Inc. stock valueWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
Edesa Biotech (EDSA) to Release Earnings on Friday - Defense World
Will Edesa Biotech Inc. stock deliver consistent dividendsBond Market & Weekly High Potential Stock Alerts - Newser
Will Edesa Biotech Inc. stock deliver better than expected guidanceJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
What technical signals suggest for Edesa Biotech Inc. stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Will Edesa Biotech Inc. stock continue upward momentumJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is Edesa Biotech Inc. stock affected by interest rate hikesJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Best data tools to analyze Edesa Biotech Inc. stock2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Can Edesa Biotech Inc. stock sustain market leadership2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
4.73%
0.92%
자본화:
|
볼륨(24시간):